{"id":2612,"date":"2024-01-10T11:39:34","date_gmt":"2024-01-10T08:39:34","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=2612"},"modified":"2024-01-10T11:43:17","modified_gmt":"2024-01-10T08:43:17","slug":"polifarma-2023teki-basarilarini-2024e-artirarak-tasiyor","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=2612","title":{"rendered":"Polifarma, 2023\u2019teki Ba\u015far\u0131lar\u0131n\u0131 2024\u2019e Art\u0131rarak Ta\u015f\u0131yor"},"content":{"rendered":"\n<p>Bu sene \u0130SO 500 listesinde 144 basamak y\u00fckselerek T\u00fcrkiye\u2019nin en b\u00fcy\u00fck sanayi kurulu\u015flar\u0131 aras\u0131nda yer alan Polifarma, Ar-Ge alan\u0131nda da bir\u00e7ok ba\u015far\u0131ya imza at\u0131yor. Polifarma\u2019n\u0131n Sat\u0131\u015f ve Pazarlamadan Sorumlu Genel M\u00fcd\u00fcr Yard\u0131mc\u0131s\u0131 Do\u011fan Servet Aksu Polifarma i\u00e7in 2023\u2019\u00fcn nas\u0131l ge\u00e7ti\u011fine dair de\u011ferlendirmelerde bulunurken, \u015firketin 2024 y\u0131l\u0131 hedeflerini de payla\u015ft\u0131.<\/p>\n\n\n\n<p>Do\u011fan Servet Aksu<strong><\/strong><\/p>\n\n\n\n<p>Polifarma Sat\u0131\u015f ve Pazarlamadan Sorumlu Genel M\u00fcd\u00fcr Yard\u0131mc\u0131s\u0131<\/p>\n\n\n\n<p><strong>2023 y\u0131l\u0131n\u0131n sonlar\u0131na geldik. Ekonomik ve sekt\u00f6rel olarak \u00f6nemli de\u011fi\u015fimlerin oldu\u011fu bir y\u0131l oldu. Siz 2023\u2019\u00fc nas\u0131l de\u011ferlendiriyorsunuz?<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSU-683x1024.jpg\" alt=\"\" class=\"wp-image-2621\" style=\"width:159px;height:239px\" width=\"159\" height=\"239\" srcset=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSU-683x1024.jpg 683w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSU-200x300.jpg 200w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSU-768x1152.jpg 768w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSU-1024x1536.jpg 1024w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSU-1365x2048.jpg 1365w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2024\/01\/DSU-scaled.jpg 1706w\" sizes=\"(max-width: 159px) 100vw, 159px\" \/><\/figure><\/div>\n\n\n<p>2023 y\u0131l\u0131 ba\u015f\u0131nda ya\u015fad\u0131\u011f\u0131m\u0131z \u00fcz\u00fcc\u00fc deprem sebebiyle buruk ba\u015flad\u0131. Ke\u015fke ya\u015fanmasayd\u0131, kay\u0131plar\u0131m\u0131z i\u00e7in \u00e7ok \u00fczg\u00fcn\u00fcz ama o d\u00f6nemde elimizden gelenin fazlas\u0131n\u0131 h\u0131zla yapmak i\u00e7in \u00e7abalamaya odakland\u0131k.<\/p>\n\n\n\n<p>Bizim i\u00e7in 2023, yeni ba\u015far\u0131lar\u0131m\u0131zdan dolay\u0131 heyecanlar ya\u015fad\u0131\u011f\u0131m\u0131z bir y\u0131l olarak ge\u00e7mekte. \u0130SO 500 listesinde 144 basamak birden y\u00fckselerek T\u00fcrkiye\u2019nin En B\u00fcy\u00fck Sanayi Kurulu\u015flar\u0131 aras\u0131na girdik. Turkishtime taraf\u0131ndan bu y\u0131l 10\u2019uncusu ger\u00e7ekle\u015ftirilen \u2018T\u00fcrkiye Ar-Ge 250 Ara\u015ft\u0131rmas\u0131\u2019n\u0131n sonu\u00e7lar\u0131na g\u00f6re \u2018En \u00c7ok Ar-Ge Harcamas\u0131 Yapan \u015eirketler\u2019 aras\u0131na girmekle kalmad\u0131k, \u2018Ar-Ge Merkezlerinde En Fazla Proje Y\u00fcr\u00fcten\u2019, \u2018Ar-Ge Merkezlerinde En \u00c7ok Marka Alan\u2019 ve \u2018Ar-Ge Merkezlerinde En \u00c7ok Kad\u0131n Personel \u0130stihdam Eden\u2019 \u015firketleri aras\u0131nda da yerimizi ald\u0131k.<\/p>\n\n\n\n<p><strong>Polifarma olarak 2023 y\u0131l\u0131nda yat\u0131r\u0131m planlamalar\u0131n\u0131z ger\u00e7ekle\u015fti mi? Hangi alanlara yat\u0131r\u0131m yapt\u0131n\u0131z?<\/strong><\/p>\n\n\n\n<p>Yat\u0131r\u0131mlar\u0131m\u0131z\u0131 \u00f6nce insan kayna\u011f\u0131m\u0131za yap\u0131yoruz. Polifarma ailemizin s\u00fcrekli \u00f6\u011frenmesi, kendini geli\u015ftirmelerini \u00f6nceli\u011fimize alarak e\u011fitim alan\u0131nda her zaman onlar\u0131 destekleyici aksiyonlar ald\u0131k. Polifarma denince akla Ar-Ge alan\u0131ndaki ba\u015far\u0131lar gelir, bu ba\u015far\u0131lar\u0131 \u00e7al\u0131\u015fanlar\u0131m\u0131za yapt\u0131\u011f\u0131m\u0131z yat\u0131r\u0131mlar neticesinde sa\u011flad\u0131\u011f\u0131m\u0131za inan\u0131yoruz. Y\u0131l i\u00e7inde bir\u00e7ok projeye ve \u00fcretime olanak sa\u011flayacak, GMP (Good Manufacturing Practices\/\u0130yi \u00dcretim Uygulamalar\u0131) onayl\u0131 \u0130la\u00e7 Etkin Madde (API) \u00dcretim Alan\u0131m\u0131z\u0131n a\u00e7\u0131l\u0131\u015f\u0131n\u0131 yapt\u0131k.<\/p>\n\n\n\n<p><strong>Polifarma 2024 y\u0131l\u0131nda neler planl\u0131yor? Gelecek y\u0131l i\u00e7in hedefleriniz nelerdir?<\/strong><\/p>\n\n\n\n<p>2024 y\u0131l\u0131na say\u0131l\u0131 g\u00fcnler kalm\u0131\u015fken sa\u011fl\u0131k ad\u0131na ger\u00e7ekle\u015ftirece\u011fimiz projelere ad\u0131m ad\u0131m yakla\u015fman\u0131n heyecan\u0131n\u0131 ya\u015f\u0131yoruz. Hastane \u00fcr\u00fcnleri alan\u0131nda liderli\u011fimizi korurken re\u00e7eteli pazarlarda girece\u011fimiz terap\u00f6tik alanlarda hem teknik hem kadro anlam\u0131nda altyap\u0131m\u0131z\u0131 kurduk ve h\u0131zla iyi bir yer edinece\u011fimize inan\u0131yoruz. Yurti\u00e7i liderli\u011fimizin yan\u0131nda, toplam sat\u0131\u015f\u0131m\u0131z\u0131n ihracattan gelen pay\u0131n\u0131 art\u0131rmay\u0131 hedefledik.<\/p>\n\n\n\n<p>2023 y\u0131l\u0131 i\u00e7inde temelini att\u0131\u011f\u0131m\u0131z ve 2024 y\u0131l\u0131 ilk aylar\u0131nda tamamlanarak faaliyete ge\u00e7ecek olan 11.000 m\u00b2\u2019lik \u00fcretim tesisimiz, tasar\u0131m ve verimlilik a\u00e7\u0131s\u0131ndan \u00fclkemizin en fonksiyonel Ar-Ge merkezlerinden biri olacak. D\u00fcnyada ilk jenerik olacak \u015fekilde geli\u015ftirme s\u00fcre\u00e7lerine devam etti\u011fimiz ve sona yakla\u015ft\u0131\u011f\u0131m\u0131z yetim ila\u00e7 ve di\u011fer biyoteknolojik ila\u00e7lar\u0131m\u0131z\u0131n \u00fcretilece\u011fi yeni \u00fcretim b\u00f6l\u00fcm\u00fc, Ar-Ge laboratuvarlar\u0131, teknik b\u00f6l\u00fcmler, y\u00f6netim ofisleri ve e\u011fitim &amp; seminer alanlar\u0131n\u0131n yer alaca\u011f\u0131 tesiste 300 bilim insan\u0131 daha istihdam edecek ve ila\u00e7 geli\u015ftirme kapasitemizi daha da art\u0131raca\u011f\u0131z. Ar-Ge ekibimizin, d\u00fcnyada ilk jenerik olacak \u015fekilde geli\u015ftirme s\u00fcre\u00e7lerine devam etti\u011fi ve sona yakla\u015ft\u0131\u011f\u0131 yetim ilac\u0131n ve biyoteknolojik ila\u00e7lar\u0131n \u00fcretimi bu alanda yap\u0131lacakt\u0131r. Sanayi Bakanl\u0131\u011f\u0131 nitelikli proje destekleme program\u0131 olan \u2018Hamle Program\u0131\u2019 ile desteklenen bu ilac\u0131n \u00fcretimi i\u00e7in tasarlanan \u00fcretim alan\u0131 \u00fclkemizde ilk ve tek olacak. Bu tesiste yer alacak 2.200 m\u00b2\u2019lik e\u011fitim ve sempozyum alan\u0131 \u2018Polifarma Akademi\u2019 ile yeni mezun \u00f6\u011frencilerin mesle\u011fe haz\u0131rlanmas\u0131n\u0131n yan\u0131 s\u0131ra, mevcut \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n teknik ve kariyer geli\u015fimini sa\u011flayacak e\u011fitim programlar\u0131n\u0131n d\u00fczenlenecek.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bu sene \u0130SO 500 listesinde 144 basamak y\u00fckselerek T\u00fcrkiye\u2019nin en b\u00fcy\u00fck sanayi kurulu\u015flar\u0131 aras\u0131nda yer alan Polifarma, Ar-Ge alan\u0131nda da bir\u00e7ok ba\u015far\u0131ya imza at\u0131yor. Polifarma\u2019n\u0131n Sat\u0131\u015f ve Pazarlamadan Sorumlu Genel M\u00fcd\u00fcr Yard\u0131mc\u0131s\u0131 Do\u011fan Servet Aksu Polifarma i\u00e7in 2023\u2019\u00fcn nas\u0131l ge\u00e7ti\u011fine dair de\u011ferlendirmelerde bulunurken, \u015firketin 2024 y\u0131l\u0131 hedeflerini de payla\u015ft\u0131.<\/p>\n","protected":false},"author":1,"featured_media":2620,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,2],"tags":[129,130,91,127,128],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2612"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2612"}],"version-history":[{"count":3,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2612\/revisions"}],"predecessor-version":[{"id":2624,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2612\/revisions\/2624"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/2620"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}